Altimmune Inc. logo

Altimmune Inc.

ALT | NASDAQ
Chart Builder DCF Calculator
$3.27
+$0.02 (+0.62%)
At close: Sep 21, 2026, 4:00 PM ET
$3.30
+$0.03 (+0.92%)
Pre-market: Sep 22, 2026, 6:06 AM ET

Market Data

Market Cap
$635.93M
Enterprise Value
$345.35M
Beta
0.18
Average Volume
4.1M
Shares Outstanding (Diluted)
185.44M
Shares Change YoY
127.6%
Institutional Ownership
55.74%
Exchange
NASDAQ
ISIN
US02155H2004

Price Performance

Price Change 1M
5.1%
Price Change 3M
12.4%
Price Change 6M
-1.2%
Price Change YTD
-6.8%
Price Change 1Y
-17.4%
Price Change 3Y
25.3%
Price Change 5Y
-78.2%
1M CAGR (ann.)
6.2%
1Y CAGR (ann.)
-15.5%
5Y CAGR (ann.)
-27.7%
All-Time CAGR
-32.8%

Valuation

PE Ratio
-4.19
Forward PE
N/A
PEG Ratio
-0.09
Forward PEG
-0.45
PS Ratio
20,513.87
Forward PS
24.70
PB Ratio
1.34
P/FCF Ratio
-8.31
P/Adj. FCF Ratio
-6.97
P/OCF Ratio
-7.98
EV/Sales
11,140.42
EV/EBIT
-3.91
EV/EBITDA
-3.92
EV/FCF
-4.51
Earnings Yield
-23.9%
FCF Yield
-12.0%
Adj. FCF Yield
-14.3%

Financial Health

Net Cash
$291.58M
Total Debt
$35.75M
Cash & Short-Term Investments
$326.32M
Total Assets
$527.21M
Current Ratio
26.78
Quick Ratio
26.78
Debt / Equity Ratio
0.08
Debt / EBITDA
-0.41
Debt / FCF
-0.47
OCF / Debt
-2.14
Interest Coverage
-28.34
Altman Z-Score
5.53
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
-48306.4%
Operating Profit Margin
-323306.5%
EBITDA Margin
-298787.1%
Net Profit Margin
-296000.0%
FCF Margin
-246974.2%
Adj. FCF Margin
-294267.7%
SBC / Revenue
47293.6%
SBC Impact (per share)
-19.1%

Returns

Return on Assets
-17.4%
Return on Equity
-31.4%
Return on Invested Capital
-19.5%
Return on Capital Employed
-19.5%
Return on Tangible Assets
-17.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
-123.3%
Revenue CAGR 5Y
-65.4%
Revenue CAGR 10Y
-40.5%
EPS CAGR 3Y
35.2%
EPS CAGR 5Y
22.4%
EPS CAGR 10Y
-64.1%
FCF CAGR 3Y
-3.3%
FCF CAGR 5Y
-3.1%
FCF CAGR 10Y
-65.6%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
15
EPS Growth Next 3Y
3.9%
Revenue Growth Next 3Y
933.3%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.14
EPS Growth Est (next Q)
-33.3%
Revenue Est (next Q)
$1.75K
Revenue Growth Est (next Q)
-65.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$6.25
Price Target Upside
91.1%

Cash Flow

Operating Cash Flow
$-76.51M
Free Cash Flow
$-76.56M
Adj. Free Cash Flow
$-91.22M
FCF Per Share
-$0.41
OCF Per Share
-$0.41
OCF/S Ratio
-246800.0%

Income Statement

Revenue
$31K
Gross Profit
$-33.61M
Operating Income
$-100.23M
EBITDA
$-88.15M
Net Income
$-91.76M
EPS (Diluted)
-$0.78
Revenue / Employee
$543.86
Profit / Employee
$-1.61M
Employees
57

© 2026 bestshares.com. All rights reserved.